Associate Professor, Medicine, Medical College of Wisconsin
Hematology
Dr. Kenneth Friedman, MD
|
|
Give Review
Kenneth Friedman practices Hematology. He graduated from State University of New York Upstate Medical University. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Kenneth Friedman is a published MD. He has 51 publications published. The most current publication "A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, respo..." He is registered with Medicare.
Publications
- A critical appraisal of one-stage and chromogenic assays of factor VIII activity.
- Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.
- Comparison of seVeral von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a...
- Crucial role for the VWF A1 domain in binding to type IV collagen.
- An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic Thrombocytopenic purpura.
- No increase in Bleeding identified in type 1 VWD subjects with D1472H sequence variation.
- Collagen Binding Provides a Sensitive Screen for Variant von Willebrand Disease.
- Use of purified fibrinogen concentrate for dysfibrinogenemia and importance of laboratory fibrinogen activity measurement.
- Comparison of Type I, Type III, and Type VI Collagen Binding Assays in Diagnosis of VWD.
- Factor VIII/von Willebrand factor concentrate therapy for ventricular assist device-associated acquired von Willebrand Disease.
- Von Willebrand factor mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.
- Von Willebrand disease in the United States: a perspective from wisconsin.
- Hematocrit and C-reactive protein predict treatment response times in ADAMTS13-deficient thrombotic microangiopathy.
- Therapeutic consequences for misdiagnosis of Type 2N von Willebrand Disease.
- Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD.
- Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.
- Value of ADAMTS13 activity and inhibitor in the postmortem diagnosis of thrombotic Thrombocytopenic purpura.
- Elevated procalcitonin and C-reactive protein as potential biomarkers of sepsis in a subpopulation of thrombotic microangiopathy patients.
- Type 2B von Willebrand Disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow.
- Comparison and stability of ADAMTS13 activity in therapeutic plasma products.
- Genetic mutations in von Willebrand Disease identified by DHPLC and DNA sequence analysis.
- The pathogenicity of von Willebrand factor in thrombotic Thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma.
- A prothrombotic phenotype in the Copenhagen rat strain.
- Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface.
- Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity.
- Human parvovirus B19 infection presenting as persistent Anemia in renal transplant recipients.
- An annotated bibliography on autologous transfusion.
- A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, respo...
- Protein C deficiency. A cause of unusual or unexplained Thrombosis.
- Allelic distribution of the glycoprotein Ia (alpha2-integrin) C807T/G873A dimorphisms among caucasian venous Thrombosis patients and six racial groups.
- Heparin cofactor activity and antithrombin III antigen levels in preeclampsia.
- Multisite study for genotyping of the factor II (prothrombin) G20210A mutation by the invader assay.
- Acquired Glanzmann's thrombasthenia as part of multiple-autoantibody Syndrome in a pediatric heart transplant patient.
- Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes.
- On improving the cost-effectiveness of autologous blood transfusion practices.
- Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded ...
- Laboratory diagnosis of von Willebrand Disease: results from a prospective and blind study in 32 laboratories worldwide using lyophilized plasmas.
- Contribution of the glycoprotein Ia 807TT, methylene tetrahydrofolate reductase 677TT and prothrombin 20210GA genotypes to prothrombotic risk among factor V 1691GA (Le...
- Enzymatic amplification of specific cDNA inserts from lambda gt11 libraries.
- Urgent reversal of warfarin with prothrombin complex concentrate.
- An amino acid polymorphism within the RGD binding domain of platelet membrane glycoprotein IIIa is responsible for the formation of the Pena/Penb alloantigen system.
- Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multipl...
- The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand Disease. Results from a p...
- Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD.
- Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand Disease.
- Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function.
- Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients.
- Evaluation and comparison of Coagulation factor activity in fresh-frozen plasma and 24-hour plasma at thaw and after 120 hours of 1 to 6°C storage.
- Lepirudin prevents lethal effects of Shiga toxin in a canine model.
- Effect of Systemic Bevacizumab in Severe Hereditary Hemorrhagic Telangiectasia (HHT) associated with Bleeding.
Schools
SUNY Upstate Medical University Syracuse
Temple University Hospital
Blood Center Se Wisc
Columbia University
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Bleeding Disorders
- View All
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
New York Presbyterian Hospital - Columbia Campus -
Temple University Hospital -
State University of New York Upstate Medical University
Hospital
-
Froedtert Memorial Lutheran Hospital
Drug Facts
| NPI NUMBER | 1124079082 | |
| NPPES Provider LastName | FRIEDMAN | |
| NPPES Provider FirstName | KENNETH | |
| NPPES Provider ZIPCode | 532263522 | |
| NPPES Provider State | WI | |
| Specialty Description | Hematology | |
| Total Claim Count | 52.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124079082 |
| Last Name Of The Provider | FRIEDMAN |
| First Name Of The Provider | KENNETH |
| View All |
Similar Doctors
|
Dr. Kathryn Bylow, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Karen L. Dallas, MDCM
This Doctor is OpenDoctor Recommended.
|
|
Christina M. Schulta, APNP |
|
|
Dr. Rubina Qamar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua Field, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexandra Harrington, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven Kroft, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Wael Saber, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ayman Saad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shamsuddin Virani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. Rizzo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Renju Vechurettu Raj, MD |